BASELINE DEMOGRAPHICS AND CLINICAL CHARACTERISTICS FROM A PROSPECTIVE, RANDOMIZED, OPEN-LABEL STUDY OF PALIPERIDONE PALMITATE LONG-ACTING INJECTION IN SUBJECTS WITH RECENT-ONSET SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER

被引：0
|
作者：
Brown, Brianne [1 ]
Turkoz, Ibrahim [2 ]
Yue, Yong [1 ]
Alphs, Larry [1 ]
机构：
[1] Janssen Sci Affairs LLC, Titusville, NJ USA
[2] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
SCHIZOPHRENIA BULLETIN | 2017年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
SA.12
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [1] A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia
    Li, H.
    Rui, Q.
    Ning, X.
    Xu, H.
    Gu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 167 - 167
  • [2] Paliperidone palmitate long-acting formulations in recent-onset psychosis: a retrospective, non-interventional study
    Recio-Barbero, M.
    Cabezas-Garduno, J.
    Fuertes-Soriano, S.
    Lopez-Atanes, M.
    Gonzalez-Briceno, J. P.
    Mentxaka, O.
    Segarra, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S320 - S321
  • [3] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Yoshiteru Takekita
    Yosuke Koshikawa
    Chiara Fabbri
    Shiho Sakai
    Naotaka Sunada
    Ai Onohara
    Keiichiro Nishida
    Masafumi Yoshimura
    Masaki Kato
    Alessandro Serretti
    Toshihiko Kinoshita
    BMC Psychiatry, 16
  • [4] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Takekita, Yoshiteru
    Koshikawa, Yosuke
    Fabbri, Chiara
    Sakai, Shiho
    Sunada, Naotaka
    Onohara, Ai
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Kato, Masaki
    Serretti, Alessandro
    Kinoshita, Toshihiko
    BMC PSYCHIATRY, 2016, 16
  • [5] The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial
    Koshikawa, Yosuke
    Takekita, Yoshiteru
    Kato, Masaki
    Sakai, Shiho
    Onohara, Ai
    Sunada, Naotaka
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Fabbri, Chiara
    Serretti, Alessandro
    Kinoshita, Toshihiko
    NEUROPSYCHOBIOLOGY, 2016, 73 (01) : 35 - 42
  • [6] Bioequivalence of paliperidone long acting injection in patients with schizophrenia: results from a randomized, cross-over, open-label study
    Shetty, Arthik
    Chakra, Amaresh
    Shah, Chirayu
    Devkare, Prashant
    Dharmadhikari, Shruti
    Mane, Amey
    Mehta, Suyog
    INDIAN JOURNAL OF PSYCHIATRY, 2024, 66 : S175 - S175
  • [7] The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder
    Alphs, Larry
    Brown, Brianne
    Turkoz, Ibrahim
    Baker, Pamela
    Fu, Dong-Jing
    Nuechterlein, Keith H.
    SCHIZOPHRENIA RESEARCH, 2022, 243 : 86 - 97
  • [8] Premorbid Functioning and Treatment Response in Recent-Onset Schizophrenia Prospective Study With Risperidone Long-Acting Injectable
    Rabinowitz, Jonathan
    Napryeyenko, Oleksandr
    Burba, Benjaminas
    Martinez, Guadalupe
    Neznanov, Nikolay G.
    Fischel, Tsvi
    Bayle, Franck J.
    Cavallaro, Roberto
    Smeraldi, Enrico
    Schreiner, Andreas
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (01) : 75 - 81
  • [9] EFFICACY OF LONG-ACTING INJECTABLE RISPERIDONE IN DELUSIONAL DISORDER: AN OPEN-LABEL, NATURALISTIC AND PROSPECTIVE STUDY
    Gonzalez Rodriguez, A.
    Molina Andreu, O.
    Imaz Gurrutxaga, M. L.
    Pons Villanueva, A.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [10] Comparison of Olanzapine Long-Acting Injection and Oral Olanzapine A 2-Year, Randomized, Open-Label Study in Outpatients With Schizophrenia
    Detke, Holland C.
    Weiden, Peter J.
    Llorca, Pierre-Michel
    Choukour, Moutaz
    Watson, Susan B.
    Brunner, Elizabeth
    Ascher-Svanum, Haya
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (04) : 426 - 434
12345